[e-drug] Losartan: seizure in the Netherlands, marketing in Switzerland

E-DRUG: Losartan: seizure in the Netherlands, marketing in Switzerland
---------------------------------------

Dear all,

The company Mepha Pharma - the No 1 generic producer in Switzerland - has been granted a license by Merck Sharp & Dohme (MSD) to market in Switzerland a generic version of the Active Pharmaceutical Ingredient Losartan Potassium, i.e. the same API contained in the generic Indian drug that has been seized by the Dutch customs authorities last December whilst transiting from India to Brazil.

Mepha issued a press release last week on the subject (available in French or German only (http://www.mepha.ch/sites/fr/medias/Documents/Communiqué%20de%20presse%20Losartan-Mepha.pdf), highlighting that the cooperation with MSD is taking place while the patent of the original product is still valid until the end of the year for the single preparation (losartan potassium, Cozaar), and until the end of 2012 for the combined preparation (losartan potassium combined with diuretic, Hyzaar).

If and how far these two issues are linked remains to be seen.

Patrick Durisch
-----
Déclaration de Berne - Berne Declaration
Patrick Durisch
Santé & Environnement - Health & Environment
Rue de Genève 52, CH - 1004 Lausanne
Tel. direct: +41 21 620 03 06
Fax: +41 21 620 03 00
Email: durisch@ladb.ch
Web: www.ladb.ch

Recherche pharmaceutique et maladies du Sud : Remédier à une négligence coupable Commandez cette nouvelle brochure thématique de la DB.
http://www.evb.ch/fr/p25014645.html